Awardee OrganizationCORIELL INSTITUTE FOR MEDICAL RESEARCH
Description
Abstract Text
The NIGMS Human Genetic Cell Repository
U42 Application
FOA No.: RFA-GM-19-002
Project Summary/Abstract
Coriell Institute for Medical Research (Coriell) proposes to maintain and expand the NIGMS
Human Genetic Cell Repository (HGCR). The NIGMS HGCR, established in 1972 at Coriell by
the National Institute of General Medical Sciences (NIGMS), provides a readily accessible,
centralized resource for biospecimens from individuals with inherited disorders, chromosomal
abnormalities, apparently healthy individuals, and individuals of diverse geographic origins for
use in biomedical research. The primary goal of the NIGMS HGCR is to stimulate and facilitate
biomedical research, teaching, and the diagnosis and prevention of human genetic diseases by
establishing and maintaining a repository of high quality, uncontaminated, well characterized,
and clinically well-documented cell lines and DNA and making these resources available to
investigators throughout the U.S. and abroad. The NIGMS HGCR mission is in line with the
NIGMS mission, which is “to support research that increases understanding of life processes
and lays the foundation for advances in disease diagnosis, treatment and prevention”. The
NIGMS HGCR’s activities, all governed by high standards of quality, will include (1) collection,
establishment, characterization, maintenance, and distribution of cell lines, (2) preparation,
storage and distribution of DNA from cell lines, (3) the development and offering of special
genetic services and biomaterials in response to customer requests, (4) maintenance of a
comprehensive database and online catalog, and (5) publicizing the NIGMS HGCR’s
collections. The NIGMS HGCR will maintain, grow and distribute the current collection of
approximately 11,800 unique cell lines, 6,400 DNA samples, and 54 human iPSC lines in its
online catalog, as well as newly acquired resources. The NIGMS HGCR will continue to create
human induced pluripotent stem cell (iPSC) lines at Coriell by reprogramming certain NIGMS
HGCR cell lines. Additionally, Coriell is committed to integrating state-of-the-art technologies
into its activities and will continue to offer a wide range of cutting edge services that enhance
the utility of the HGCR collection to the genetic research community.
Public Health Relevance Statement
The NIGMS Human Genetic Cell Repository
U42 Application
FOA No.: RFA-GM-19-002
Project Narrative
The NIGMS Human Genetic Cell Repository (HGCR) stimulates and facilitates biomedical
research, teaching, and the diagnosis and prevention of human genetic diseases by providing
well-characterized and high-quality cell lines, DNA, and iPSCs for use in biomedical research.
The NIGMS HGCR currently contains approximately 11,800 unique cell lines, 6,400 DNA
samples, and 54 human iPSC lines representing a variety of disease states, chromosomal
abnormalities, apparently healthy individuals and many distinct human populations. The NIGMS
HGCR also develops and offers a wide range of cutting-edge special genetic services and
biomaterials in response to the research community’s needs.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdvertisementsAreaBiocompatible MaterialsBiomedical ResearchCatalogsCell LineCellsChromosome abnormalityClinicalCollectionCommunitiesCustomDNADatabasesDevelopmentDiagnosisDiseaseEducational process of instructingElectronic MailExhibitsFamilyFoundationsFunding OpportunitiesGenetic DiseasesGenetic ResearchGenetic ServicesGeographyGoalsHereditary DiseaseHumanHuman GeneticsIndividualInformation DistributionInstitutesInstitutional Review BoardsInterviewJournalsLifeMaintenanceMedical ResearchMissionNational Institute of General Medical SciencesNewsletterPamphletsPatientsPopulationPreparationPreventionProceduresProcessProtocols documentationQuality ControlRNAReportingResearchResearch PersonnelResearch SupportResourcesSamplingSecureServicesTechnologyTestingUpdatecell repositorycomputerizeddisease diagnosisestablished cell linehigh standardinduced pluripotent stem cellinnovationinterestmeetingspermanent cell linerepositoryresponsesocial media
No Sub Projects information available for 5U42GM115336-08
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U42GM115336-08
Patents
No Patents information available for 5U42GM115336-08
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U42GM115336-08
Clinical Studies
No Clinical Studies information available for 5U42GM115336-08
News and More
Related News Releases
No news release information available for 5U42GM115336-08
History
No Historical information available for 5U42GM115336-08
Similar Projects
No Similar Projects information available for 5U42GM115336-08